Literature DB >> 17380223

Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.

Ken Shimamoto1, Miyako Kusumoto, Rieko Sakai, Hirota Watanabe, Syunichi Ihara, Natsuka Koike, Masatoshi Kawana.   

Abstract

BACKGROUND: Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) levels were characterized in subjects with mitral regurgitation (MR).
METHODS: Sixty-two cases of moderate or severe chronic MR were studied. The blood levels of neurohormonal factors were stratified by the known MR prognostic factors of New York Heart Association (NYHA) functional class, left ventricular end-diastolic diameters, left ventricular end-systolic diameter (LVDs), ejection fraction (EF), left atrial diameter and presence of atrial fibrillation (AF).
RESULTS: ANP levels were higher in NYHA class II and lower in classes I and III/IV (P=0.0206). BNP levels were higher in NYHA class II than class I (P=0.0355). The BNP/ANP ratio was significantly higher in NYHA classes II and III/IV than in class I (P=0.0007). To differentiate between NYHA classes I/II and III/IV, a cut-off BNP/ANP ratio of 2.97 produced a sensitivity of 78% and specificity of 87%. Compared with subjects in sinus rhythm, patients with AF had an enlarged left atrium and lower ANP levels. The BNP/ANP ratio correlated significantly with left atrial diameter, LVDs and EF (r=0.429, P=0.0017; r=0.351, P=0.0117; and r=-0.349, P=0.0122; respectively), and was significantly higher among all the known operative indications for MR tested (LVDs 45 mm or more, EF 60% or less, NYHA class II or greater and AF; P=0.0073, P=0.003, P=0.0102 and P=0.0149, respectively).
CONCLUSIONS: In chronic MR, levels of ANP and BNP, and the BNP/ANP ratio are potential indicators of disease severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380223      PMCID: PMC2647887          DOI: 10.1016/s0828-282x(07)70758-4

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  37 in total

1.  Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence.

Authors:  Y Seino; S Shimai; C Ibuki; K Itoh; T Takano; H Hayakawa
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

2.  Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.

Authors:  S Inoue; Y Murakami; K Sano; H Katoh; T Shimada
Journal:  J Card Fail       Date:  2000-06       Impact factor: 5.712

Review 3.  Prospects for using a blood sample in the diagnosis of heart failure.

Authors:  A D Struthers
Journal:  QJM       Date:  1995-05

4.  Left ventricular function in chronic mitral regurgitation: preoperative and postoperative comparison.

Authors:  W J Corin; G Sütsch; T Murakami; O N Krogmann; M Turina; O M Hess
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

5.  Rat brain natriuretic peptide is localized in atrial granules and released into the circulation.

Authors:  G Thibault; C Charbonneau; J Bilodeau; E L Schiffrin; R Garcia
Journal:  Am J Physiol       Date:  1992-08

6.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

Authors:  O Nakagawa; Y Ogawa; H Itoh; S Suga; Y Komatsu; I Kishimoto; K Nishino; T Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; K Okumura; H Ogawa; M Jougasaki; M Mukoyama; K Nakao; H Imura
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

8.  Light and electron microscopic localization of brain natriuretic peptide in relation to atrial natriuretic peptide in porcine atrium. Immunohistocytochemical study using specific monoclonal antibodies.

Authors:  K Hasegawa; H Fujiwara; H Itoh; K Nakao; T Fujiwara; H Imura; C Kawai
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

9.  Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction.

Authors:  M R Starling; M M Kirsh; D G Montgomery; M D Gross
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

10.  Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide.

Authors:  Y Ogawa; K Nakao; M Mukoyama; K Hosoda; G Shirakami; H Arai; Y Saito; S Suga; M Jougasaki; H Imura
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

View more
  7 in total

1.  The role of B-type and other natriuretic peptides in health and disease.

Authors:  Ashok Krishnaswami
Journal:  Perm J       Date:  2008

2.  The time-course changes of NT-proBNP and tissue Doppler indices in patients undergoing mitral valve replacement.

Authors:  D R Prakaschandra; T Esterhuizen; D P Naidoo
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

3.  C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function.

Authors:  Jens Buttgereit; Julia Shanks; Dan Li; Guoliang Hao; Arvinder Athwal; Thomas H Langenickel; Hannah Wright; Andrey C da Costa Goncalves; Jan Monti; Ralph Plehm; Elena Popova; Fatimunnisa Qadri; Irina Lapidus; Brent Ryan; Cemil Özcelik; David J Paterson; Michael Bader; Neil Herring
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

Review 4.  Left atrial deformation: Useful index for early detection of cardiac damage in chronic mitral regurgitation.

Authors:  M Cameli; E Incampo; S Mondillo
Journal:  Int J Cardiol Heart Vasc       Date:  2017-10-03

Review 5.  Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation.

Authors:  Giovanna Gallo; Maurizio Forte; Rosita Stanzione; Maria Cotugno; Franca Bianchi; Simona Marchitti; Andrea Berni; Massimo Volpe; Speranza Rubattu
Journal:  J Clin Med       Date:  2020-05-05       Impact factor: 4.241

6.  Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study.

Authors:  Raoul Stahrenberg; André Duvinage; Meinhard Mende; Götz Gelbrich; Wiebke Auf der Heide; Hans-Dirk Düngen; Lutz Binder; Kathleen Nolte; Christoph Herrmann-Lingen; Gerd Hasenfuß; Burkert Pieske; Rolf Wachter; Frank Edelmann
Journal:  ESC Heart Fail       Date:  2015-04-27

7.  B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation.

Authors:  Eman M Abdel Fattah; Hany Younan Azer Girgis; Khaled El Khashab; Zeinab A Ashour; Ghada M Ezzat
Journal:  Heart Views       Date:  2016 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.